Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

AXIOM IMPLANT ?3.4 x 12.0: medical device reports filed with FDA

1,253 reports name it, 2021–2026. Manufacturer given most often on reports: Anthogyr. Product code DZE.

1,253
device reports naming the brand
0% of all MAUDE reports · about 232 a year
212
reports, 12 months to August 2026
189 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

1,253 medical device reports received by FDA name the brand "AXIOM IMPLANT ?3.4 x 12.0" (endosseous dental implant); the manufacturer given most often on reports is Anthogyr; received from February 2021 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

212 reports arrived in the 12 months to August 2026, up 12% from 189 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (82%), loss of osseointegration (16.6%) and fracture (0.3%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

03263Sep 2021: 4Oct 2021: 10Nov 2021: 19Dec 2021: 142022Jan 2022: 63Feb 2022: 27Mar 2022: 7Apr 2022: 16May 2022: 5Jun 2022: 31Jul 2022: 19Aug 2022: 12Sep 2022: 18Oct 2022: 12Nov 2022: 26Dec 2022: 222023Jan 2023: 4Feb 2023: 11Mar 2023: 9Apr 2023: 10May 2023: 33Jun 2023: 25Jul 2023: 36Aug 2023: 20Sep 2023: 34Oct 2023: 24Nov 2023: 25Dec 2023: 362024Jan 2024: 15Feb 2024: 17Mar 2024: 16Apr 2024: 14May 2024: 25Jun 2024: 18Jul 2024: 7Aug 2024: 17Sep 2024: 13Oct 2024: 18Nov 2024: 7Dec 2024: 152025Jan 2025: 9Feb 2025: 17Mar 2025: 18Apr 2025: 7May 2025: 0Jun 2025: 59Jul 2025: 11Aug 2025: 15Sep 2025: 14Oct 2025: 12Nov 2025: 18Dec 2025: 222026Jan 2026: 17Feb 2026: 9Mar 2026: 29Apr 2026: 21May 2026: 16Jun 2026: 19Jul 2026: 16Aug 2026: 19

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01342672021: 19820212022: 25820222023: 26720232024: 18220242025: 20220252026: 1462026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,253
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,253
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,02882%62.8%
Loss of osseointegration20816.6%22.4%
Fracturea broken bone40.3%1.6%
Difficult to insertthe device was hard to insert20.2%0.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis17013.6%
Painpain, site not specified836.6%
Inflammationinflammation655.2%
Swelling/ edema403.2%
Fistula211.7%
Hemorrhage/blood loss/bleeding211.7%
Numbnessnumbness110.9%
Abscessa collection of pus100.8%
Hypersensitivity/allergic reaction80.6%
Hyperresponsive to stimuli50.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureAXIOM IMPLANT ?3.4 x 12.0Product code DZEAll MAUDE reports
Reports1,2533,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about AXIOM IMPLANT ?3.4 x 12.0 reports

How many FDA reports name AXIOM IMPLANT ?3.4 x 12.0?

1,253 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 212 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (82%), loss of osseointegration (16.6%), fracture (0.3%) and difficult to insert (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that AXIOM IMPLANT ?3.4 x 12.0 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.